author-photo

Yasuko Shoji

Pfizer

4

Papers

38

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccines.

2021 Vaccine
Show All
- Source
- Cite
- Save
Citations (0)
Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populations.

2018 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (3)
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults

2015 Human Vaccines & Immunotherapeutics
Show All
- Source
- Cite
- Save
Citations (30)